Quotes on the small-cap MAIA Biotechnology jumped almost 6% yesterday, Tuesday, February 4, after the company revealed phase II clinical trial results for its drug that is said to offer a fundamentally new approach to cancer treatment. The therapy has proved to be superior to existing treatments, MAIA claims, and…